Inhibitor Therapeutics INTI
OTC INTI
$0.10 +0.00 (+0.00%)
At close: Sep 29, 2026 · 4:00 PM EDT

Inhibitor Therapeutics (INTI) Times Interest Earned (2014 - 2022)

Updated

Inhibitor Therapeutics' (INTI) Times Interest Earned stood at -126.23 in Q4 2022.

Analysis

Inhibitor Therapeutics (INTI) Times Interest Earned (2014 - 2022) Analysis & Trends

For FY2022, Inhibitor Therapeutics' Times Interest Earned came in at -28.32.

  • Across earlier years, Times Interest Earned came in at -21.93 in FY2021.
  • The Q4 2022 figure is the lowest quarterly Times Interest Earned since Q4 2014.
  • Per Business Quant, the preceding three quarters came in at -9.08 (Q3 2022), -10.47 (Q2 2022) and -17.28 (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.41
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 10.28
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 7.27
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 5.22
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -42.08
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Inhibitor Therapeutics 17.38 Mn 17.38 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 -126.23
Sep 30, 2022 -9.08
Jun 30, 2022 -10.47
Mar 31, 2022 -17.28
Dec 31, 2014 -944.35
Sep 30, 2014 -372.96
Jun 30, 2014 -84.65
Mar 31, 2014 -19.56
API Access

Inhibitor Therapeutics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=INTI&period=max&api_key=YOUR_API_KEY